Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Mallinckrodt
Moodys
Harvard Business School
Boehringer Ingelheim

Last Updated: August 19, 2022

Investigational Drug Information for GWP42006


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What is the drug development status for GWP42006?

GWP42006 is an investigational drug.

There have been 4 clinical trials for GWP42006. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2016.

The most common disease conditions in clinical trials are Seizures, Child Development Disorders, Pervasive, and Autistic Disorder. The leading clinical trial sponsors are GW Research Ltd and [disabled in preview].

There are two hundred and eighty-eight US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for GWP42006
TitleSponsorPhase
Safety and Tolerability of Cannabidivarin (CBDV) in Children and Young Adults With Autism Spectrum DisorderGW Research LtdPhase 2
A Study of GWP42006 in People With Focal Seizures - Part BGW Research LtdPhase 2
A Study of GWP42006 in People With Focal Seizures - Part AGW Research LtdPhase 2

See all GWP42006 clinical trials

Clinical Trial Summary for GWP42006

Top disease conditions for GWP42006
Top clinical trial sponsors for GWP42006

See all GWP42006 clinical trials

US Patents for GWP42006

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
GWP42006 See Plans and Pricing Pharmaceutical formulations GW Pharma Limited (Cambridge, GB) See Plans and Pricing
GWP42006 See Plans and Pricing Pre-spray emulsions and powders containing non-polar compounds Virun, Inc. (Pomona, CA) See Plans and Pricing
GWP42006 See Plans and Pricing Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms NANOSPHERE HEALTH SCIENCES, LLC (Greenwood Village, CO) See Plans and Pricing
GWP42006 See Plans and Pricing Water-soluble phytocannabinoid formulations See Plans and Pricing
GWP42006 See Plans and Pricing Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids BODYBIO INC. (Millville, NJ) See Plans and Pricing
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for GWP42006

Drugname Country Document Number Estimated Expiration Related US Patent
GWP42006 Australia AU2002231970 2021-02-14 See Plans and Pricing
GWP42006 Canada CA2438097 2021-02-14 See Plans and Pricing
GWP42006 Canada CA2533400 2021-02-14 See Plans and Pricing
GWP42006 China CN1886117 2021-02-14 See Plans and Pricing
GWP42006 Cyprus CY1115072 2021-02-14 See Plans and Pricing
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Express Scripts
Mallinckrodt
Moodys
Harvard Business School
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.